Sagimet Biosciences (SGMT) Short Interest Ratio & Short Volume $9.15 +0.47 (+5.41%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$8.99 -0.16 (-1.75%) As of 09:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sagimet Biosciences Short Interest DataSagimet Biosciences (SGMT) has a short interest of 3.81 million shares, representing 16.13% of the float (the number of shares available for trading by the public). This marks a 4.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 1.08 million shares to cover all short positions.Current Short Interest3,810,000 sharesPrevious Short Interest3,660,000 sharesChange Vs. Previous Month+4.10%Dollar Volume Sold Short$31.51 millionShort Interest Ratio2.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares30,670,000 sharesFloat Size23,620,000 sharesShort Percent of Float16.13%Today's Trading Volume821,859 sharesAverage Trading Volume1,076,712 sharesToday's Volume Vs. Average76% Short Selling Sagimet Biosciences? Sign up to receive the latest short interest report for Sagimet Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSGMT Short Interest Over TimeSGMT Days to Cover Over TimeSGMT Percentage of Float Shorted Over Time Sagimet Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20253,810,000 shares $31.51 million +4.1%16.1%2.7 $8.27 5/31/20253,660,000 shares $13.21 million +2.0%15.5%3.8 $3.61 5/15/20253,590,000 shares $11.88 million -7.7%15.2%7.3 $3.31 4/30/20253,890,000 shares $13.42 million +1.6%16.7%7 $3.45 4/15/20253,830,000 shares $8.31 million -3.3%16.5%6 $2.17 3/31/20253,960,000 shares $12.91 million -5.5%17.0%4.5 $3.26 3/15/20254,190,000 shares $15.67 million -15.9%18.0%5.1 $3.74 2/28/20254,980,000 shares $18.48 million -9.0%21.4%5.3 $3.71 2/15/20255,470,000 shares $23.25 million +5.6%23.5%5.8 $4.25 1/31/20255,180,000 shares $22.79 million +8.4%24.1%5.5 $4.40 Get the Latest News and Ratings for SGMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20254,780,000 shares $19.93 million +14.9%23.4%5.2 $4.17 12/31/20244,160,000 shares $18.72 million +0.2%20.4%4.7 $4.50 12/15/20244,150,000 shares $18.22 million +0.5%20.3%2.7 $4.39 11/30/20244,130,000 shares $23.50 million -5.3%20.2%2.8 $5.69 11/15/20244,360,000 shares $20.62 million +4.6%21.4%3 $4.73 10/31/20244,170,000 shares $21.48 million +4.8%19.7%3 $5.15 10/15/20243,980,000 shares $20.42 million +102.0%18.8%3 $5.13 9/30/20241,970,000 shares $5.46 million -4.8%9.3%1.6 $2.77 9/15/20242,070,000 shares $7.70 million +11.3%9.8%5 $3.72 8/31/20241,860,000 shares $5.73 million +2.8%8.8%4.1 $3.08 8/15/20241,810,000 shares $5.00 million +7.1%8.6%3.9 $2.76 7/31/20241,690,000 shares $5.68 million +1.2%8.1%3.4 $3.36 7/15/20241,670,000 shares $5.68 million -26.8%8.0%3.1 $3.40 6/30/20242,280,000 shares $7.80 million +0.9%11.0%4.1 $3.42 6/15/20242,260,000 shares $9.36 million +1.4%10.9%3.9 $4.14 5/31/20242,230,000 shares $11.89 million +4.2%10.7%3.2 $5.33 5/15/20242,140,000 shares $9.89 million -2.7%10.3%3.1 $4.62 4/30/20242,200,000 shares $8.58 million +6.3%12.8%2.3 $3.90 4/15/20242,070,000 shares $9.44 million -11.9%12.0%1.8 $4.56 3/31/20242,350,000 shares $12.74 million +31.3%19.4%1.4 $5.42 3/15/20241,790,000 shares $7.23 million +10.5%14.8%1.1 $4.04 2/29/20241,620,000 shares $9.93 million +3.9%13.4%1.2 $6.13 2/15/20241,560,000 shares $13.51 million +44.4%12.9%1.2 $8.66 1/31/20241,080,000 shares $10.24 million No Change9.0%0.9 $9.48 SGMT Short Interest - Frequently Asked Questions What is Sagimet Biosciences' current short interest? Short interest is the volume of Sagimet Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 3,810,000 shares of SGMT short. 16.13% of Sagimet Biosciences' shares are currently sold short. Learn More on Sagimet Biosciences' current short interest. What is a good short interest ratio for Sagimet Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SGMT shares currently have a short interest ratio of 3.0. Learn More on Sagimet Biosciences's short interest ratio. What is a good short interest percentage for Sagimet Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.13% of Sagimet Biosciences' floating shares are currently sold short. Is Sagimet Biosciences' short interest increasing or decreasing? Sagimet Biosciences saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 3,810,000 shares, an increase of 4.1% from the previous total of 3,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sagimet Biosciences' float size? Sagimet Biosciences currently has issued a total of 30,670,000 shares. Some of Sagimet Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sagimet Biosciences currently has a public float of 23,620,000 shares. How does Sagimet Biosciences' short interest compare to its competitors? 16.13% of Sagimet Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sagimet Biosciences: Collegium Pharmaceutical, Inc. (15.65%), Akebia Therapeutics, Inc. (7.26%), Spyre Therapeutics, Inc. (24.53%), Mineralys Therapeutics, Inc. (15.19%), Avadel Pharmaceuticals PLC. (11.58%), Pharvaris N.V. (4.50%), Nurix Therapeutics, Inc. (20.45%), Ardelyx, Inc. (11.98%), Oric Pharmaceuticals, Inc. (16.01%), Praxis Precision Medicines, Inc. (9.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Sagimet Biosciences stock? Short selling SGMT is an investing strategy that aims to generate trading profit from Sagimet Biosciences as its price is falling. SGMT shares are trading up $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sagimet Biosciences? A short squeeze for Sagimet Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SGMT, which in turn drives the price of the stock up even further. How often is Sagimet Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGMT, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Collegium Pharmaceutical Short Squeeze Akebia Therapeutics Short Squeeze Spyre Therapeutics Short Squeeze Mineralys Therapeutics Short Squeeze Avadel Pharmaceuticals Short Squeeze Pharvaris Short Squeeze Nurix Therapeutics Short Squeeze Ardelyx Short Squeeze Oric Pharmaceuticals Short Squeeze Praxis Precision Medicines Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGMT) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.